Skip to content

3 minute read

Chlamydia partners, retesting and reinfection

Written by Hi-Doctor clinical content teamPublished 4 July 2026

Treatment does not create immunity. Partner care and correctly timed follow-up reduce the chance of passing infection back and forth.

Chlamydia partners, retesting and reinfection, article cover image
Share:

DIRECT ANSWER

An online consultation lets an EU-licensed doctor review your case and, if appropriate, issue a prescription that is valid across the EU.

Doctor reply in under 2 hours

Average doctor reply under 2 hours; prescription within 24 hours if approved.

EU-licensed doctors

Every case is reviewed by a licensed clinician.

Valid across the EU

Approved prescriptions can be used at any EU pharmacy.

HOW IT WORKS

From consultation to collection

  1. 1

    Consultation

    Answer a secure medical questionnaire online.

  2. 2

    Doctor reviews

    An EU-licensed doctor personally assesses your case.

  3. 3

    Prescription in less than 2 hours on average

    If approved, your prescription is issued in less than 2 hours on average.

  4. 4

    Collect at any EU pharmacy

    Use an approved prescription at a pharmacy anywhere in the EU.

A chlamydia diagnosis often brings two worries: how to tell partners and whether the infection will return. Chlamydia can be treated, but treatment does not create immunity. Reinfection is possible if an exposed partner has not been assessed or if a new exposure occurs.

Partner notification is practical healthcare

A sexual-health service can help identify which recent partners should be contacted based on local guidance and the history. Notification can often be anonymous. A positive result cannot reliably prove who had the infection first or when it was acquired, so the conversation should focus on testing and treatment rather than certainty or accusation.

Test of cure and retesting are different

A test of cure checks whether treatment cleared infection and is used in selected circumstances, such as pregnancy or when the regimen or response raises concern. Retesting later looks mainly for reinfection. Testing too soon after treatment may detect residual bacterial material, so follow the interval given by the service.

Reducing reinfection

Complete treatment, observe the advised no-sex interval, ensure relevant partners receive care and use condoms with new or untested partners. A wider STI screen may be offered because the same exposure can transmit more than one infection. Prevention is a shared plan, not a punishment.

When to seek help

Seek prompt in-person care for severe pelvic or testicular pain, fever, vomiting, pregnancy with concerning symptoms, eye pain after possible exposure, or feeling acutely unwell. Do not use leftover antibiotics or share treatment. Until a clinician confirms the appropriate interval after treatment, avoid sexual contact that could pass the infection on.

What to prepare for a medical review

A safe review includes the date and type of possible exposure, symptoms, pregnancy or breastfeeding, allergies, current medicines, and which anatomical sites may need testing. Partner notification and testing are part of care, not an accusation. A negative test from one site does not necessarily answer a question about another exposed site.

A calm next step

Ask the service for wording or anonymous-notification support if telling a partner feels difficult or unsafe. Put any repeat-test date in your calendar before closing the result message.

Clinical sources used: European Centre for Disease Prevention and Control chlamydia factsheet and local sexual-health service instructions.

Dr. Alejandro Infante
General medicine · Reg. 080869277

Own your health

Doctor-reviewed guides and new treatments. At most two emails a month.

All content on this page has been medically reviewed by: Dr. Alejandro Infante, General medicine, on 27 July 2026. Registration: 080869277 View profile

Pay nothing if a doctor doesn't approve your treatment. Every consultation is fully refundable. How refunds work